Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells

Fig. 6

Expression of immunomodulatory genes in passage 0 cells and pIPCs using semiquantitative reverse-transcriptase PCR. a Expression of immunomodulatory genes in passage 0 cells. b Expression of immunomodulatory genes in pIPCs. Expression of IDO, PGE2, HGF, TGF-β, and Galectin genes was observed at both lower passage (P0) as well as in pIPCs. However, no expression of the iNOS gene was observed. Lane (L) 1: low molecular weight ladder; L2: GAPDH (128 bp); L3: β-Actin (70 bp); L4: IDO (109 bp); L5: PGE2 (104 bp); L6: HGF (117 bp); L7: TGF-β (138 bp); L8: Galectin (77 bp); L9: iNOS (92 bp); L10: 100 bp ladder

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512